Champions Oncology, Inc. (CSBR)
4.995
+0.06
(+1.32%)
USD |
NASDAQ |
Aug 31, 16:00
Champions Oncology Cash from Operations (Annual) : -4.472M for April 30, 2026
Cash from Operations (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| April 30, 2026 | -4.472M |
| April 30, 2025 | 7.386M |
| April 30, 2024 | -6.137M |
| April 30, 2023 | 3.972M |
| April 30, 2022 | 6.497M |
| April 30, 2021 | -1.681M |
| April 30, 2020 | 2.905M |
| April 30, 2019 | 1.862M |
| April 30, 2018 | -1.226M |
| April 30, 2017 | -2.84M |
| April 30, 2016 | -6.465M |
| April 30, 2015 | -9.632M |
| April 30, 2014 | -3.46M |
| April 30, 2013 | -4.292M |
| April 30, 2012 | -5.227M |
| Date | Value |
|---|---|
| April 30, 2011 | -0.054M |
| April 30, 2010 | -2.10M |
| April 30, 2009 | -0.888M |
| April 30, 2008 | 0.7924M |
| April 30, 2007 | -0.0785M |
| April 30, 2006 | -0.094M |
| April 30, 2005 | -0.0356M |
| April 30, 2004 | -0.0677M |
| April 30, 2003 | -0.2481M |
| April 30, 2002 | -0.0327M |
| April 30, 2001 | 0.1447M |
| April 30, 2000 | -0.0184M |
| April 30, 1999 | 0.1055M |
| April 30, 1998 | 0.4227M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Medpace Holdings, Inc. | 713.22M |
| Avantor, Inc. | 623.80M |
| Personalis, Inc. | -74.95M |
| Adaptive Biotechnologies Corp. | -45.99M |
| 10X Genomics, Inc. | 136.05M |